65
49
Growth Score
-6 pts
Heat Score
16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
268472
Oncotelic is a cancer immunotherapy company
Vuong Trieu: CEOPast Role: Sorrento Therapeutics, BOD & CSO
Fatih Uckun: CMO
About the Company
Oncotelic Inc. operates as a cancer immunotherapy company. The Company engaged in developing a unique TGF-b antisense therapy which has demonstrated the ability to break immune tolerance in mid-stage clinical trials for the treatment of glioblastoma and pancreatic cancer. Oncotelic serves customers in the United States.
